Tg Therapeutics (TGTX) analyst forecast and price target
Analyst forecast
Consensus of 8 analyst ratings
Based on 4 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| JP Morgan | Maintained | Overweight | $72.00 from $65.00 | Aug 7, 2026 |
| B. Riley Securities | Maintained | Buy | $86.00 from $55.00 | Jul 27, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $77.00 from $70.00 | Jul 13, 2026 |
| B of A Securities | Maintained | Underperform | $20.00 from $17.00 | Jul 7, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $70.00 | Jul 6, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $70.00 | May 27, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $70.00 from $60.00 | May 6, 2026 |
| JP Morgan | Maintained | Overweight | $46.00 from $49.00 | Feb 2, 2026 |
| Goldman Sachs | Maintained | Neutral | $39.00 from $37.00 | Jan 15, 2026 |
| JP Morgan | Maintained | Overweight | $49.00 from $46.00 | Nov 3, 2025 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $60.00 | Oct 6, 2025 |
| B. Riley Securities | Maintained | Buy | $55.00 from $53.00 | Sep 17, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $55.00 | Mar 4, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $55.00 | Jan 15, 2025 |
| JP Morgan | Maintained | Overweight | $43.00 from $30.00 | Nov 25, 2024 |
| Goldman Sachs | Maintained | Neutral | $22.00 from $20.00 | Nov 5, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $55.00 from $49.00 | Nov 5, 2024 |
| TD Cowen | Initiated Coverage | Buy | $50.00 | Oct 29, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $49.00 | Sep 18, 2024 |
| Goldman Sachs | Maintained | Neutral | $20.00 from $18.00 | Aug 7, 2024 |
Frequently asked questions
What is the price target for TGTX stock?
The average 12-month analyst price target for Tg Therapeutics (TGTX) is $63.75, with a high estimate of $86.00 and a low of $20.00, across 4 analysts.
Is TGTX a buy, sell, or hold?
Analysts covering Tg Therapeutics currently average a Buy rating: 7 buy, 0 hold and 1 sell, from 8 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for TGTX?
The average price target of $63.75 implies 17.40% upside from the last price of $54.30.
What is the latest analyst rating on TGTX?
On Aug 7, 2026, JP Morgan maintained Tg Therapeutics at Overweight with a price target of $72.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.